Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17692718rdf:typepubmed:Citationlld:pubmed
pubmed-article:17692718lifeskim:mentionsumls-concept:C0001675lld:lifeskim
pubmed-article:17692718lifeskim:mentionsumls-concept:C0205653lld:lifeskim
pubmed-article:17692718lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:17692718lifeskim:mentionsumls-concept:C0001617lld:lifeskim
pubmed-article:17692718lifeskim:mentionsumls-concept:C0054201lld:lifeskim
pubmed-article:17692718lifeskim:mentionsumls-concept:C0004048lld:lifeskim
pubmed-article:17692718lifeskim:mentionsumls-concept:C0205081lld:lifeskim
pubmed-article:17692718lifeskim:mentionsumls-concept:C1960048lld:lifeskim
pubmed-article:17692718lifeskim:mentionsumls-concept:C1382107lld:lifeskim
pubmed-article:17692718lifeskim:mentionsumls-concept:C1967611lld:lifeskim
pubmed-article:17692718lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:17692718lifeskim:mentionsumls-concept:C0150108lld:lifeskim
pubmed-article:17692718pubmed:issue6lld:pubmed
pubmed-article:17692718pubmed:dateCreated2007-8-13lld:pubmed
pubmed-article:17692718pubmed:abstractTextNebulized budesonide inhalation suspension (BIS) is approved in the United States for children with asthma aged 1 to 8 years.lld:pubmed
pubmed-article:17692718pubmed:languageenglld:pubmed
pubmed-article:17692718pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17692718pubmed:citationSubsetIMlld:pubmed
pubmed-article:17692718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17692718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17692718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17692718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17692718pubmed:statusMEDLINElld:pubmed
pubmed-article:17692718pubmed:monthJunlld:pubmed
pubmed-article:17692718pubmed:issn0149-2918lld:pubmed
pubmed-article:17692718pubmed:authorpubmed-author:MurphyKevinKlld:pubmed
pubmed-article:17692718pubmed:authorpubmed-author:SilkoffPhilip...lld:pubmed
pubmed-article:17692718pubmed:authorpubmed-author:UryniakThomas...lld:pubmed
pubmed-article:17692718pubmed:authorpubmed-author:NoonanMichael...lld:pubmed
pubmed-article:17692718pubmed:issnTypePrintlld:pubmed
pubmed-article:17692718pubmed:volume29lld:pubmed
pubmed-article:17692718pubmed:ownerNLMlld:pubmed
pubmed-article:17692718pubmed:authorsCompleteYlld:pubmed
pubmed-article:17692718pubmed:pagination1013-26lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:meshHeadingpubmed-meshheading:17692718...lld:pubmed
pubmed-article:17692718pubmed:year2007lld:pubmed
pubmed-article:17692718pubmed:articleTitleA 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.lld:pubmed
pubmed-article:17692718pubmed:affiliationMidwest Children's Chest Physicians, Omaha, Nebraska 68114, USA. murphknsc@aol.comlld:pubmed
pubmed-article:17692718pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17692718pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:17692718pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17692718pubmed:publicationTypeMulticenter Studylld:pubmed